BHVN - Biohaven Pharmaceutical Holding Company Ltd.

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures

Market cap (intra-day) 53.85B
Enterprise value 33.47B
Trailing P/E N/A
Forward P/E 1-11.51
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)3,347.68
Price/book (mrq)31.51
Enterprise value/revenue 33,016.67
Enterprise value/EBITDA 6-6.04

Trading information

Stock price history

Beta (5Y monthly) 1.42
52-week change 361.84%
S&P500 52-week change 314.99%
52-week high 378.75
52-week low 326.56
50-day moving average 371.37
200-day moving average 352.68

Share statistics

Avg vol (3-month) 3771.63k
Avg vol (10-day) 3570.15k
Shares outstanding 558.29M
Float 50.7M
% held by insiders 113.91%
% held by institutions 197.21%
Shares short (14 Jul 2020) 49.84M
Short ratio (14 Jul 2020) 411.18
Short % of float (14 Jul 2020) 423.14%
Short % of shares outstanding (14 Jul 2020) 416.81%
Shares short (prior month 14 Jun 2020) 410.2M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2019
Most-recent quarter (mrq)30 Mar 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)-50,009.12%

Management effectiveness

Return on assets (ttm)-92.51%
Return on equity (ttm)-584.04%

Income statement

Revenue (ttm)1.15M
Revenue per share (ttm)0.02
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -574.8M
Net income avi to common (ttm)-639.44M
Diluted EPS (ttm)-12.41
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)428.24M
Total cash per share (mrq)7.32
Total debt (mrq)152.03M
Total debt/equity (mrq)124.66
Current ratio (mrq)3.89
Book value per share (mrq)2.09

Cash flow statement

Operating cash flow (ttm)-481.18M
Levered free cash flow (ttm)-302.97M